Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.

NCT02738918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant
Acute Antibody Mediated Rejection
Mild Immunologic Risk Factor

Interventions

DRUG: Nulojix (Belatacept)

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]